Published in Neurology on January 10, 2006
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia | NCT00545974
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.84
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs (2010) 1.72
An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord (2009) 1.25
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement (2012) 1.14
Improving response inhibition systems in frontotemporal dementia with citalopram. Brain (2015) 1.12
New approaches to the treatment of frontotemporal lobar degeneration. Curr Opin Neurol (2008) 1.12
FTD and ALS: a tale of two diseases. Curr Alzheimer Res (2011) 1.12
Frontotemporal dementias: a review. Ann Gen Psychiatry (2007) 1.11
The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective. ISRN Neurol (2013) 1.09
Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med (2014) 1.03
Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen (2010) 1.01
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia. Expert Rev Neurother (2011) 0.91
Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 0.89
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease. Brain (2014) 0.89
The case of a 48 year-old woman with bizarre and complex delusions. Nat Rev Neurol (2010) 0.89
Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition. Neuropsychopharmacology (2012) 0.88
Diagnosis and management of behavioral variant frontotemporal dementia. Biol Psychiatry (2013) 0.88
Diagnosis and management of behavioral issues in frontotemporal dementia. Curr Neurol Neurosci Rep (2012) 0.86
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology (Berl) (2007) 0.85
Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability. Stem Cell Reports (2016) 0.84
Frontotemporal dementia: An updated overview. Indian J Psychiatry (2009) 0.84
Mechanisms of granulin deficiency: lessons from cellular and animal models. Mol Neurobiol (2012) 0.84
Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. Neuroimage Clin (2013) 0.83
Dementia syndromes: evaluation and treatment. Expert Rev Neurother (2007) 0.83
A review of executive function deficits and pharmacological management in children and adolescents. J Can Acad Child Adolesc Psychiatry (2012) 0.83
Platelet serotonin level predicts survival in amyotrophic lateral sclerosis. PLoS One (2010) 0.82
Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses - the case of behavioral variant frontotemporal dementia. Cortex (2014) 0.82
Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease. J R Soc Interface (2013) 0.82
The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia. J Cogn Neurosci (2013) 0.81
No effect of DC brain polarization on verbal fluency in patients with advanced frontotemporal dementia. Clin Neurophysiol (2007) 0.81
BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia. J Neural Transm (Vienna) (2010) 0.81
Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia. Expert Opin Ther Targets (2008) 0.80
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. Curr Treat Options Neurol (2016) 0.80
Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options. Neurodegener Dis Manag (2011) 0.80
Frontotemporal dementia and primary progressive aphasia, a review. Neuropsychiatr Dis Treat (2014) 0.80
Treatment of frontotemporal dementia. Curr Treat Options Neurol (2014) 0.79
Stimulant treatment of frontotemporal dementia in 8 patients. J Clin Psychiatry (2008) 0.77
Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes. Transl Neurodegener (2014) 0.77
Aggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury. CNS Spectr (2014) 0.76
Monoaminergic neuropathology in Alzheimer's disease. Prog Neurobiol (2016) 0.76
A review on primary progressive aphasia. Neuropsychiatr Dis Treat (2007) 0.76
Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer's disease. Alzheimer Dis Assoc Disord (2014) 0.76
Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia. Dement Geriatr Cogn Dis Extra (2015) 0.76
Metabolic changes over the course of aging in a mouse model of tau deposition. Neurobiol Aging (2016) 0.75
Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series. Alzheimer Dis Assoc Disord (2016) 0.75
Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective. J Nucleic Acids (2013) 0.75
Managing cognition in progressive supranuclear palsy. Neurodegener Dis Manag (2016) 0.75
Emerging Diagnostic and Therapeutic Strategies for Tauopathies. Curr Neurol Neurosci Rep (2017) 0.75
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65
Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA (2005) 6.20
The prevalence of frontotemporal dementia. Neurology (2002) 5.73
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry (1994) 5.40
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA (2003) 5.23
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA (2003) 4.16
Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med (1990) 3.80
Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex (1998) 2.43
Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med (2005) 2.27
Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology (2000) 1.86
Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry (2003) 1.76
FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol (1999) 1.75
Neocortical cholinergic neurons in elderly people. Lancet (1977) 1.68
Dietary changes, compulsions and sexual behavior in frontotemporal degeneration. Dementia (1995) 1.55
The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography. Arch Neurol (1991) 1.44
Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci (1997) 1.22
Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci (1982) 1.21
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry (2004) 1.21
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol (2005) 1.17
Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord (2004) 1.15
Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease. J Neuropathol Exp Neurol (1986) 1.15
Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol (2003) 1.14
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology (2006) 1.14
Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci (1995) 1.13
Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain (1998) 1.11
Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging (2004) 1.11
Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl) (2003) 1.06
Basal nucleus of Meynert. A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea. J Neurol Sci (1983) 1.02
Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol (1991) 0.97
The Klüver-Bucy Syndrome in man. A clinico-anatomical contribution to the function of the medial temporal lobe structures. Psychiatr Neurol (Basel) (1966) 0.91
Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration. Int J Geriatr Psychiatry (2003) 0.90
Neurochemical features of frontotemporal dementia. Dement Geriatr Cogn Disord (1999) 0.90
The organization of serotonergic projections to cerebral cortex in primates: retrograde transport studies. Neuroscience (1991) 0.89
Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch Gerontol Geriatr (1984) 0.89
Neurons and their dendrites in frontotemporal dementia. Dement Geriatr Cogn Disord (1999) 0.89
Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients. Am J Alzheimers Dis Other Demen (2003) 0.89
Long-term care of patients with frontotemporal dementia. J Am Med Dir Assoc (2003) 0.88
Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology (1983) 0.88
Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology (2002) 0.88
Mechanisms of antipsychotic-induced weight gain. J Clin Psychiatry (2001) 0.87
Quantitative electroencephalography in frontotemporal dementia with methylphenidate response: a case study. Clin EEG Neurosci (2004) 0.87
Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. J Clin Psychopharmacol (2000) 0.87
Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol (2001) 0.87
Amantadine for executive dysfunction syndrome in patients with dementia. Psychosomatics (2004) 0.86
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging (1999) 0.85
The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type. Psychopharmacology (Berl) (1996) 0.84
Frontotemporal dementia. Med Clin North Am (2002) 0.84
Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement Geriatr Cogn Disord (2004) 0.83
Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation. Int J Geriatr Psychiatry (2002) 0.82
Neurochemical observations in a case of Pick's disease. J Neurol Sci (1980) 0.82
Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results. Acta Neurol Scand (1994) 0.82
Bromocriptine treatment for perseveration in demented patients. Alzheimer Dis Assoc Disord (1998) 0.82
Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol (1988) 0.82
Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1993) 0.81
Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual. J Neuropathol Exp Neurol (1994) 0.81
Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2002) 0.81
Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. Arch Neurol (1991) 0.81
Therapy and management of frontal lobe dementia patients. Neurology (2001) 0.81
Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 0.80
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. J Neurol Sci (1983) 0.80
Efficacy of acetylcholinesterase inhibitors in frontotemporal dementia. Ann Pharmacother (2004) 0.79
Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction. J Neurol Sci (1988) 0.79
Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia (1993) 0.79
Lack of cholinergic deficit in the neocortex in Pick's disease. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.78
Biological correlates of clinical subgroups of Alzheimer's disease. Dement Geriatr Cogn Disord (2002) 0.78
A juvenile case of frontotemporal dementia: neurochemical and neuropathological investigations. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.78
Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies. J Neurol Neurosurg Psychiatry (2003) 0.78
Functional imaging, the frontal lobes, and dementia. Dementia (1993) 0.77
Imaging the serotonergic system in depression. Eur Arch Psychiatry Clin Neurosci (2001) 0.77
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Refereeing mortus est, vivat refereeing. Cortex (2002) 8.44
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA (2003) 4.16
Human fronto-mesolimbic networks guide decisions about charitable donation. Proc Natl Acad Sci U S A (2006) 4.06
The human amygdala: an evolved system for relevance detection. Rev Neurosci (2003) 3.99
Opinion: the neural basis of human moral cognition. Nat Rev Neurosci (2005) 3.28
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol (2007) 2.72
Human prefrontal cortex: processing and representational perspectives. Nat Rev Neurosci (2003) 2.65
Functional networks in emotional moral and nonmoral social judgments. Neuroimage (2002) 2.27
The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res (2009) 2.05
Social concepts are represented in the superior anterior temporal cortex. Proc Natl Acad Sci U S A (2007) 2.05
Cognitive decline in older adults with a history of traumatic brain injury. Lancet Neurol (2012) 2.04
Working memory retention systems: a state of activated long-term memory. Behav Brain Sci (2003) 1.85
Neural correlates of trust. Proc Natl Acad Sci U S A (2007) 1.85
Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol Psychiatry (2004) 1.84
Imaging cortical anatomy by high-resolution MR at 3.0T: detection of the stripe of Gennari in visual area 17. Magn Reson Med (2002) 1.83
Focal brain damage protects against post-traumatic stress disorder in combat veterans. Nat Neurosci (2007) 1.82
The neural basis of human social values: evidence from functional MRI. Cereb Cortex (2008) 1.71
Superior parietal cortex is critical for the manipulation of information in working memory. J Neurosci (2009) 1.68
An integrative architecture for general intelligence and executive function revealed by lesion mapping. Brain (2012) 1.67
The role of the human prefrontal cortex in social cognition and moral judgment. Annu Rev Neurosci (2010) 1.64
User-friendly software for the analysis of brain lesions (ABLe). Comput Methods Programs Biomed (2007) 1.63
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. BMC Neurol (2006) 1.60
Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J Neurosci (2008) 1.55
Dorsolateral prefrontal contributions to human working memory. Cortex (2012) 1.55
Quantification of brain lesions using interactive automated software. Behav Res Methods Instrum Comput (2002) 1.51
Recharging cognition with DC brain polarization. Trends Cogn Sci (2005) 1.49
Alzheimer's disease presenting as corticobasal syndrome. Mov Disord (2006) 1.46
Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol (2007) 1.39
Posttraumatic stress disorder: the role of medial prefrontal cortex and amygdala. Neuroscientist (2009) 1.39
Social conceptual impairments in frontotemporal lobar degeneration with right anterior temporal hypometabolism. Brain (2009) 1.38
The medial prefrontal cortex mediates social event knowledge. Trends Cogn Sci (2009) 1.33
Dissociating the roles of the rostral anterior cingulate and the lateral prefrontal cortices in performing two tasks simultaneously or successively. Cereb Cortex (2003) 1.30
The self as a moral agent: linking the neural bases of social agency and moral sensitivity. Soc Neurosci (2007) 1.27
Impairment of social perception associated with lesions of the prefrontal cortex. Am J Psychiatry (2004) 1.26
Childhood sexual abuse and adolescent pregnancy: a meta-analytic update. J Pediatr Psychol (2008) 1.25
Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol (2006) 1.22
Phineas gauged: decision-making and the human prefrontal cortex. Neuropsychologia (2003) 1.20
Demographic, structural and genetic predictors of late cognitive decline after penetrating head injury. Brain (2007) 1.19
Structured event complexes in the medial prefrontal cortex support counterfactual representations for future planning. Philos Trans R Soc Lond B Biol Sci (2009) 1.18
A psychological and neuroanatomical model of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (2008) 1.18
Damage to the fronto-polar cortex is associated with impaired multitasking. PLoS One (2008) 1.17
The neural bases of key competencies of emotional intelligence. Proc Natl Acad Sci U S A (2009) 1.16
An evolutionarily adaptive neural architecture for social reasoning. Trends Neurosci (2009) 1.14
The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury. J Neurosci (2011) 1.14
Biomarkers in the diagnosis of Alzheimer's disease: are we ready? J Geriatr Psychiatry Neurol (2006) 1.10
Orbitofrontal contributions to human working memory. Cereb Cortex (2010) 1.10
Neural correlates of automatic beliefs about gender and race. Hum Brain Mapp (2007) 1.10
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Politics on the brain: an FMRI investigation. Soc Neurosci (2006) 1.06
The roles of timing and task order during task switching. Neuroimage (2002) 1.06
Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging (2012) 1.05
Damage to the left ventromedial prefrontal cortex impacts affective theory of mind. Soc Cogn Affect Neurosci (2011) 1.05
Reward-related activity in the human motor cortex. Eur J Neurosci (2008) 1.05
The roles of the cerebellum and basal ganglia in timing and error prediction. Eur J Neurosci (2002) 1.05
Impairment of prosocial sentiments is associated with frontopolar and septal damage in frontotemporal dementia. Neuroimage (2010) 1.05
Neural correlates of economic game playing. Philos Trans R Soc Lond B Biol Sci (2008) 1.04
Cognitive and neural foundations of religious belief. Proc Natl Acad Sci U S A (2009) 1.03
Fronto-parietal regulation of media violence exposure in adolescents: a multi-method study. Soc Cogn Affect Neurosci (2010) 1.02
Social contracts and precautions activate different neurological systems: an fMRI investigation of deontic reasoning. Neuroimage (2005) 1.02
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol (2011) 1.01
Architecture of fluid intelligence and working memory revealed by lesion mapping. Brain Struct Funct (2013) 1.01
Brain activation in processing temporal sequence: an fMRI study. Neuroimage (2004) 1.01
Event frequency modulates the processing of daily life activities in human medial prefrontal cortex. Cereb Cortex (2006) 1.01
Dorsolateral prefrontal contributions to human intelligence. Neuropsychologia (2012) 1.00
Only spontaneous counterfactual thinking is impaired in patients with prefrontal cortex lesions. Brain Res Cogn Brain Res (2005) 0.99
Hemispheric specialization in human prefrontal cortex for resolving certain and uncertain inferences. Cereb Cortex (2006) 0.99
The hippocampal system mediates logical reasoning about familiar spatial environments. J Cogn Neurosci (2004) 0.97
Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci (2010) 0.97
Deficits in social knowledge following damage to ventromedial prefrontal cortex. J Neuropsychiatry Clin Neurosci (2005) 0.97
Bilateral frontal transcranial direct current stimulation: Failure to replicate classic findings in healthy subjects. Clin Neurophysiol (2008) 0.96
Medial prefrontal and subcortical mechanisms underlying the acquisition of motor and cognitive action sequences in humans. Neuron (2002) 0.96
Neural correlates of anxiety in healthy volunteers: a voxel-based morphometry study. J Neuropsychiatry Clin Neurosci (2009) 0.95
Genetic variability in CHMP2B and frontotemporal dementia. Neurodegener Dis (2006) 0.93
Selective functional integration between anterior temporal and distinct fronto-mesolimbic regions during guilt and indignation. Neuroimage (2010) 0.92
Psychological structure and neural correlates of event knowledge. Cereb Cortex (2004) 0.92
Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol (2009) 0.92
"Studying injured minds" - the Vietnam head injury study and 40 years of brain injury research. Front Neurol (2011) 0.92
Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia. Neurocase (2010) 0.91
Developmental effects of aggressive behavior in male adolescents assessed with structural and functional brain imaging. Soc Cogn Affect Neurosci (2009) 0.90
Transverse patterning and human amnesia. J Cogn Neurosci (2006) 0.90
FUS and TDP43 genetic variability in FTD and CBS. Neurobiol Aging (2011) 0.90
A role for right ventrolateral prefrontal cortex in reasoning about indeterminate relations. Neuropsychologia (2009) 0.89
Asymmetrical involvement of frontal lobes in social reasoning. Brain (2004) 0.89
Transitive inference reasoning is impaired by focal lesions in parietal cortex rather than rostrolateral prefrontal cortex. Neuropsychologia (2012) 0.88
Long-term memory is the representational basis for semantic verbal short-term memory. Psychophysiology (2005) 0.88
Behavioral norms for condensed moral vignettes. Soc Cogn Affect Neurosci (2010) 0.88
Head of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study. Mov Disord (2006) 0.88
Antecedent trauma exposure and risk of depression in the perinatal period. J Clin Psychiatry (2013) 0.88
BDNF polymorphism predicts general intelligence after penetrating traumatic brain injury. PLoS One (2011) 0.88
Observing social gestures: an fMRI study. Exp Brain Res (2008) 0.88
In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17. Neurodegener Dis (2008) 0.88
Social neuroscience: the second phase. Front Hum Neurosci (2013) 0.87
Distributed neural system for emotional intelligence revealed by lesion mapping. Soc Cogn Affect Neurosci (2012) 0.87
Individualism, conservatism, and radicalism as criteria for processing political beliefs: a parametric fMRI study. Soc Neurosci (2009) 0.87
Cortico-cortical networks in patients with ideomotor apraxia as revealed by EEG coherence analysis. Neurosci Lett (2008) 0.86
Discourse production following injury to the dorsolateral prefrontal cortex. Neuropsychologia (2012) 0.86
The frontopolar cortex mediates event knowledge complexity: a parametric functional MRI study. Neuroreport (2009) 0.85
Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndrome. Arch Neurol (2009) 0.85